Wound Treatments - Colombia

Date: September 22, 2010
Pages: 41
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: WD62B8512A3EN
Leaflet:

Download PDF Leaflet

Wound treatments increased by 9% in current value terms, reaching Col$13.2 billion. Local companies' products continued to experience strong growth and global companies continue investing heavily in marketing. This category has high household penetration, due to the importance of having sticking plasters and other wound treatments in the First Aid cabinet in every home, which empowers market dynamics. Players are usually active in this category, with promotions, new packaging and sticking...

Euromonitor International's Wound Treatments in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Other Wound Treatments, Sticking Plasters.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Wound Treatments market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Consumer Healthcare Is Affected As GDP Growth Continues To Slow Down
Self-medication Habits Limit the Growth of Consumer Healthcare in Colombia
International Companies Continue To Lead in 2009
Foreign Investment and Local Purchases Strengthen Distribution Channels
Moderate Growth Expected Over the Forecast Period
Key Trends and Developments
Self-medication Remains A Widespread Issue in Colombia
Anti-tobacco Legislation in 2009 Reinforces Law Passed in 2008
Colombian Elders Are Increasingly Targeted by Pharmaceutical Companies
Generics Gain Strength During Economic Downturn
Functional Products Are Expected To Threaten Share of Vitamins and Dietary Supplements
Market Indicators
  Table1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table2 Life Expectancy at Birth 2004-2009
Market Data
  Table3 Sales of Consumer Health by Sector: Value 2004-2009
  Table4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table5 Consumer Health Company Shares by Value 2005-2009
  Table6 Consumer Health Brand Shares by Value 2006-2009
  Table7 Penetration of Private Label by Sector 2004-2009
  Table8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Switches
Definitions
  Summary 1 Research Sources
Biochem Farmaceútica De Colombia SA
Strategic Direction
Key Facts
  Summary 2 Biochem Farmaceútica de Colombia SA: Key Facts
  Summary 3 Biochem Farmaceútica de Colombia SA: Operational Indicators
Company Background
Production
  Summary 4 Biochem Farmacéutica de Colombia SA: Production Statistics 2009
Competitive Positioning
  Summary 5 Biochem Farmaceútica de Colombia SA: Competitive Position 2009
Biogen De Colombia Sa, Laboratorios
Strategic Direction
Key Facts
  Summary 6 Biogen de Colombia SA, Laboratorios: Key Facts
  Summary 7 Biogen de Colombia SA, Laboratorios: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 8 Biogen de Colombia SA, Laboratorios: Competitive Position 2009
Laboratorios California SA
Strategic Direction
Key Facts
  Summary 9 Laboratorios California SA: Key Facts
  Summary 10 Laboratorios California SA: Operational Indicators
Company Background
Production
  Summary 11 Laboratorios California SA: Production Statistics 2009
Competitive Positioning
  Summary 12 Laboratorios California SA: Competitive Position 2009
Laboratorios Genéricos Farmacéuticos SA
Strategic Direction
Key Facts
  Summary 13 Laboratorios Genéricos Farmacéuticos SA: Key Facts
  Summary 14 Laboratorios Genéricos Farmacéuticos SA: Operational Indicators
Company Background
Competitive Positioning
  Summary 15 Laboratorios Genéricos Farmacéuticos SA: Competitive Position 2009
Laboratorios Natural Freshly Infabo Ltda
Strategic Direction
Key Facts
  Summary 16 Laboratorios Natural Freshly Infabo Ltda: Key Facts
  Summary 17 Laboratorios Natural Freshly Infabo Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 18 Laboratorios Natural Freshly Infabo LTDA: Competitive Position 2009
Lafrancol SA
Strategic Direction
Key Facts
  Summary 19 Lafrancol SA: Key Facts
  Summary 20 Lafrancol SA: Operational Indicators
Company Background
Production
  Summary 21 Lafrancol SA: Production Statistics 2009
Competitive Positioning
  Summary 22 Lafrancol SA: Competitive Position 2009
Omnilife Manufactura De Colombia Ltda
Strategic Direction
Key Facts
  Summary 23 Omnilife Manufactura de Colombia Ltda: Key Facts
  Summary 24 Omnilife Manufactura de Colombia Ltda: Operational Indicators
Company Background
Production
  Summary 25 Omnilife Manufactura de Colombia Ltda: Production Statistics 2009
Competitive Positioning
  Summary 26 Omnilife Manufactura de Colombia Ltda: Competitive Position 2009
Tecnoquímicas SA
Strategic Direction
Key Facts
  Summary 27 Tecnoquímicas SA: Key Facts
  Summary 28 Tecnoquímicas SA: Operational Indicators
Company Background
Production
  Summary 29 Tecnoquímicas SA: Production Statistics 2009
Competitive Positioning
  Summary 30 Tecnoquímicas SA: Competitive Position 2009
Trends
Category Data
  Table12 Sales of Wound Treatments by Subsector: Value 2004-2009
  Table13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
  Table14 Wound Treatments Company Shares by Value 2005-2009
  Table15 Wound Treatments Brand Shares by Value 2006-2009
  Table16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
  Table17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
Skip to top


Wound Treatments - Egypt US$ 990.00 Apr, 2010 · 26 pages
Wound Treatments - France US$ 990.00 Apr, 2010 · 49 pages
Wound Treatments - Germany US$ 990.00 Apr, 2010 · 41 pages
Wound Treatments - Greece US$ 990.00 Mar, 2010 · 34 pages
Wound Treatments - Guatemala US$ 990.00 May, 2010 · 20 pages

Ask Your Question

Wound Treatments - Colombia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: